HanAll Biopharma, Active Community... Stock Price Up 0.58%.
At this time, posts about HanAll Biopharma are surging on portals and securities communities. Today, foreigners have net sold 116,079 shares of HanAll Biopharma, and institutions have net sold 87,000 shares, according to provisional data. HanAll Biopharma is known as an R&D-focused pharmaceutical and bio company.
As of 11:30 AM on the 26th, HanAll Biopharma's stock price is 34,800 KRW, up 0.58% from the previous day, with a trading volume of 2,743,932 shares, which is 147.56% of the 5-day average trading volume. On August 20, HanAll Biopharma was a market topic for its "strength due to Johnson & Johnson's competitor acquisition news."
In addition to HanAll Biopharma, posts by investors are also surging for Green Cross Holdings 2 Preferred (005257), Central Bio (051980), and ECS (067010).
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Experts Are Already Watching Closely..."Target Stock Price 970,000 Won" Now Only the Uptrend Remains [Weekend Money]
※ Source: AI Investment Assistant AI Lasso
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
